276 related articles for article (PubMed ID: 18614429)
21. Bioavailability of two oral formulations of a single dose of levofloxacin 500 mg: an open-label, randomized, two-period crossover comparison in healthy Mexican volunteers.
Galan-Herrera JF; Poo JL; Rosales-Sanchez O; Fuentes-Fuentes E; Cariño L; Burke-Fraga V; Namur S; Parra MG
Clin Ther; 2009 Aug; 31(8):1796-803. PubMed ID: 19808138
[TBL] [Abstract][Full Text] [Related]
22. Plasma concentrations of enrofloxacin and its active metabolite ciprofloxacin in dogs following single oral administration of enrofloxacin at 7.5, 10, or 20 mg/kg.
Boothe DM; Boeckh A; Boothe HW; Wilkie S; Jones S
Vet Ther; 2002; 3(4):409-19. PubMed ID: 12584678
[TBL] [Abstract][Full Text] [Related]
23. Formulation and comparative bioavailability of 2 ciprofloxacin sustained release tablets.
Zaid AN; Qaddomi A; Khammash S
Arzneimittelforschung; 2012 Jul; 62(7):319-23. PubMed ID: 22549239
[TBL] [Abstract][Full Text] [Related]
24. The pharmacokinetics of orbifloxacin in the horse following oral and intravenous administration.
Davis JL; Papich MG; Weingarten A
J Vet Pharmacol Ther; 2006 Jun; 29(3):191-7. PubMed ID: 16669863
[TBL] [Abstract][Full Text] [Related]
25. Bioequivalence of ciprofloxacin tablet formulations assessed in Indonesian volunteers.
Harahap Y; Prasaja B; Indriati E; Lusthom W; Lipin
Int J Clin Pharmacol Ther; 2007 Jun; 45(6):373-6. PubMed ID: 17595895
[TBL] [Abstract][Full Text] [Related]
26. Bioequivalence evaluation of two D-limonene capsule formulations in healthy Chinese volunteers.
Liu T; Guo Y; Gao Z; Chen Z; Jiang X
Pharmazie; 2008 Oct; 63(10):718-20. PubMed ID: 18972832
[TBL] [Abstract][Full Text] [Related]
27. Comparative bioavailability of two brands of ciprofloxacin.
Seth SD; Beotra A; Seth S
J Assoc Physicians India; 1995 May; 43(5):327-30. PubMed ID: 9081961
[TBL] [Abstract][Full Text] [Related]
28. Lack of bioequivalence of ciprofloxacin when administered with calcium-fortified orange juice: a new twist on an old interaction.
Neuhofel AL; Wilton JH; Victory JM; Hejmanowsk LG; Amsden GW
J Clin Pharmacol; 2002 Apr; 42(4):461-6. PubMed ID: 11936572
[TBL] [Abstract][Full Text] [Related]
29. Pharmacokinetics of ciprofloxacin in normal rabbits and changes observed in induced dehydrated state.
Bashir S; Jamshaid M; Ahmad B; Iqbal J
Pak J Pharm Sci; 2008 Jul; 21(3):225-9. PubMed ID: 18614416
[TBL] [Abstract][Full Text] [Related]
30. Pharmacokinetics and tissue distribution of enrofloxacin and its active metabolite ciprofloxacin in calves.
Davis JL; Foster DM; Papich MG
J Vet Pharmacol Ther; 2007 Dec; 30(6):564-71. PubMed ID: 17991225
[TBL] [Abstract][Full Text] [Related]
31. Bioequivalence of two brands of ciprofloxacin 750 mg tablets (Sarf and Ciprobay) in healthy human volunteers.
Abdallah RM; Alam SM; Awaad FM; Dham R; El-Kersh A; El-Laithy A; Shalby MH; Shihabeddin M; El-Walily AF; Yacout M; Zaman Q
Drug Dev Ind Pharm; 2002 Apr; 28(4):423-9. PubMed ID: 12056535
[TBL] [Abstract][Full Text] [Related]
32. Bioequivalence and tolerability of two clopidogrel salt preparations, besylate and bisulfate: a randomized, open-label, crossover study in healthy Korean male subjects.
Kim SD; Kang W; Lee HW; Park DJ; Ahn JH; Kim MJ; Kim EY; Kim SW; Nam HS; Na HJ; Yoon YR
Clin Ther; 2009 Apr; 31(4):793-803. PubMed ID: 19446152
[TBL] [Abstract][Full Text] [Related]
33. Bioequivalence evaluation of three different oral formulations of ciprofloxacin in healthy volunteers.
Maya MT; Gonçalves NJ; Silva NE; Filipe AE; Morais JA
Eur J Drug Metab Pharmacokinet; 2003; 28(2):129-36. PubMed ID: 12877571
[TBL] [Abstract][Full Text] [Related]
34. Ciprofloxacin prolonged-release tablets do not affect warfarin pharmacokinetics and pharmacodynamics.
Washington C; Hou SY; Hughes NC; Campanella C; Berner B
J Clin Pharmacol; 2007 Oct; 47(10):1320-6. PubMed ID: 17724088
[TBL] [Abstract][Full Text] [Related]
35. Development of a prolonged-release gastroretentive tablet formulation of ciprofloxacin hydrochloride: pharmacokinetic characterization in healthy human volunteers.
Mostafavi A; Emami J; Varshosaz J; Davies NM; Rezazadeh M
Int J Pharm; 2011 May; 409(1-2):128-36. PubMed ID: 21371548
[TBL] [Abstract][Full Text] [Related]
36. Pharmacokinetics and residues of ciprofloxacin and its metabolites in broiler chickens.
Anadón A; Martínez-Larrañaga MR; Iturbe J; Martínez MA; Díaz MJ; Frejo MT; Martínez M
Res Vet Sci; 2001 Oct; 71(2):101-9. PubMed ID: 11883887
[TBL] [Abstract][Full Text] [Related]
37. Pharmacokinetics of ciprofloxacin after single intravenous and repeat oral administration to cats.
Albarellos GA; Kreil VE; Landoni MF
J Vet Pharmacol Ther; 2004 Jun; 27(3):155-62. PubMed ID: 15189301
[TBL] [Abstract][Full Text] [Related]
38. Bioequivalence assay between orally disintegrating and conventional tablet formulations in healthy volunteers.
Armando YP; Schramm SG; Silva Mde F; Kano EK; Koono EE; Porta V; Serra CH
Int J Pharm; 2009 Jan; 366(1-2):149-53. PubMed ID: 18848869
[TBL] [Abstract][Full Text] [Related]
39. Effect of simulated microgravity on the disposition and tissue penetration of ciprofloxacin in healthy volunteers.
Schuck EL; Grant M; Derendorf H
J Clin Pharmacol; 2005 Jul; 45(7):822-31. PubMed ID: 15951472
[TBL] [Abstract][Full Text] [Related]
40. Bioequivalence evaluation of two brands of amoxicillin/clavulanic acid 250/125 mg combination tablets in healthy human volunteers: use of replicate design approach.
Idkaidek NM; Al-Ghazawi A; Najib NM
Biopharm Drug Dispos; 2004 Dec; 25(9):367-72. PubMed ID: 15495146
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
